Spero Therapeutics Inc (SPRO)

Finanzdaten der Spero Therapeutics Inc-Aktie (SPRO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	188.63% 73.52	25.47	2.716	2.069	47.44
Operating Expenses	16.12% 22.99	27.41	15.61	16.30	21.52
Benefits Costs and Expenses	78.38	-	14.63	15.34	20.67
Costs And Expenses	30.43% 19.07	27.41	14.63	15.34	20.67
Operating Income/Loss	2,713% 50.53	-1.934	-12.89	-14.23	25.92
Nonoperating Income/Loss	11.28% 1.046	0.94	0.976	0.961	0.847
Income/Loss From Continuing Operations Before Tax	119.06% -4.855	25.47	-11.91	-13.27	26.77
Income Tax Expense/Benefit	82.50% 0.387	2.211	-	-	-
Income/Loss From Continuing Operations After Tax	1,697% 51.19	-3.205	-11.91	-13.27	26.77
Net Income/Loss	1,697% 51.19	-3.205	-11.91	-13.27	26.77
Preferred Stock Dividends And Other Adjustments	200.00% 0.015	0.005	0.014	-0.034	0.014
Attributable To Noncontrolling Interest	200.00% -0.015	-0.005	-0.014	0.034	-92.84
Basic Average Shares	99.81% 0.0998	52.71	52.57	52.53	3.7509
Diluted Average Shares	99.27% 0.3853	52.71	52.57	52.53	3.7509
Basic Earnings Per Share	1,717% 0.97	-0.06	-0.23	-0.25	0.93
Diluted Earnings Per Share	1,717% 0.97	-0.06	-0.23	-0.25	0.93
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	200.00% 0.015	0.005	0.014	-0.034	0.014